A panel of 24 international experts developed 19 consensus statements to guide clinicians in referring patients with large nonpedunculated colorectal…
Browsing: Clinical Updates
The FDA has approved Gilead Sciences’ drug Livdelzi (bulevirtide) for the treatment of primary biliary cholangitis (PBC), a chronic liver…
Johns Hopkins Kimmel Cancer Center has developed Esopredict, a PCR-based test that helps predict the progression of Barrett’s esophagus to…
The article discusses a study showing that a top-down treatment approach, which uses biologics early in therapy, appears more effective…
The study published in JAMA Network Open demonstrates that fecal immunochemical test (FIT) screening significantly reduces colorectal cancer (CRC) mortality…
A recent study published in The American Journal of Gastroenterology examines the risk of colorectal cancer following adenoma removal. The…
Guardant Health’s COSMOS study, published in Clinical Cancer Research, validates the effectiveness of the Guardant Reveal liquid biopsy test in…
Chronic liver disease (CLD) often progresses silently, making early identification of at-risk patients crucial. Traditionally, liver biopsies were used for…
The article “Advanced Tissue Resection in Gastroenterology: Indications, Role, and Techniques” explores the use of advanced tissue resection techniques in…